M. Lee et al. / Bioorg. Med. Chem. Lett. 23 (2013) 3170–3174
3173
[
7
(
d
H
4.81 (1H, d, J = 13.4 Hz, H-7a) and 4.67 (1H, d, J = 13.6 Hz, H-
b)], signals for two anomeric protons of glucose moiety [d 4.61
H
1H, d, J = 7.9 Hz, H-1 ) and d 4.84 (1H, d, J = 7.7 Hz, H-1 )], which
25 and 50
l
M. Although PPAR
c
and C/EBP
a
are known as master
H
regulators of adipogenesis, this study showed conflicting results
(Fig. 2C and D). These results suggested that idescarpin (1) affects
the suppression of adipocyte differentiation, in spite of the activa-
0
00
were similar to those of compound 6 except for an additional
glucose moiety. Acid hydrolysis of compound 8 and HILIC–MS
analysis afforded
and mass spectra (m/z 160.83 [C
[
[
hydrolysis were compared with the authentic sample of
The coupling constant of doublet at d
(
The HMBC correlations of H-1 –C-1 and H-1 –C-6 indicated that
the two glucose units formed (1 ? 6) glycosidic linkage and were
located at C-1 of the aglycone (Fig. 1). Therefore, compound 8
tion of PPAR
c expression. SREBP1c regulates the expression of
D
-glucose.14 The retention time (t
R
7.02 min)
genes related to the metabolism of lipids and cholesterol and the
enzymes involved in lipogenesis and fatty acid desaturation. The
ꢁ
6
6
H
12
O
6
ꢁH
2
OꢁH] , 178.77
ꢁ
ꢁ
C
6
H
12
O
6
ꢁH] ,
224.79
[C
H
6 12
O
6
+HCOOHꢁH] ,
386.84
activation of SREBP1c promotes the expression of FAS and SCD-
ꢁ
8,27
2C
6
H
12
O
6
ꢁH
2
O+HCOOHꢁH] ) of the sugar released on acid
-glucose.
4.84 (J = 7.7) and d 4.61
J = 7.9) established the b-configuration of the glucose moiety.
1.
As shown in Figure 2C, the decrease in mRNA levels of
D
SREBP1c, SCD-1, and FAS by idescarpin (1) during adipocyte differ-
entiation also implies that the inhibition of adipocyte differentia-
tion was mediated by the regulation of lipogenesis. Idescarpin (1)
slightly reduced the gene expression of aP2, which plays central
roles in the linkage pathway of obesity to insulin resistance and
H
H
0
00
0
1
1
fatty acid metabolism.
was confirmed as 6-(oxymethyl)-2-hydroxyphenyl-O-b-
pyranosyl-(1 ? 6)-b- -glucopyranoside.
-(oxymethyl)-2-hydroxyphenyl-O-b-
-glucopyranoside (8) Yellowish syrup; ½
MeOH); IR (KBr) max: 3365, 2925, 1738, 1652, 1596, 1558, 1507,
473, 1365, 1296, 1202, 1034 cm ; R
D
-gluco-
In conclusion, it was demonstrated that methanolic extract of I.
polycarpa fruits and its isolated constituent affect the suppression
of adipogenesis in 3T3-L1 cells. In the course of the mechanismic
investigation of these natural products, we suggested that idescar-
pin (1), the most potent constituent of I. polycarpa can be the
potent therapeutic agent against obesity and diabetes though the
D
6
D
D-glucopyranosyl-(1 ? 6)
2
D
5
-
b-
a : +27.0 (c 0.2,
ꢂ
m
ꢁ
1
1
f
: 0.15 (Silica TLC, C/M/
W = 15:4:1), 0.86 (RP TLC, 40% M); H NMR (500 MHz, CD OD),
OD), see Table 1; HRFABMS
13, 463.1452).
1
3
anti-adipogenic activity and the up-regulation of PPARc expression.
1
3
see Table 1; C NMR (125 MHz, CD
3
ꢁ
m/z 463.1454 [MꢁH] (calcd for C19
28
H O
1
5
Acknowledgments
The nine known compounds were identified as idescarpin (1),
1
6
17
18
poliothrysin (2), (ꢁ)-idesolide (3), E-p-methylcoumarate (4),
1
2
18
19
This work was supported by the Global Leading Technology
Program (GLST-OSP project No. 10039303) of the Office of Strategic
R&D Planning (OSP) funded by the Ministry of Knowledge Econ-
omy, Republic of Korea.
idesolidine (5),
idesin (6),
salirepin (7),
hydrangeifolin I
2
0
21
(
9), itoside I (10), by comparing the measured spectroscopic
data with published values. To examine the effect of the com-
pounds (1–10) isolated from I. polycarpa on the differentiation of
preadipocytes into adipocytes, confluent 3T3-L1 preadipocytes
were treated with various concentrations of compounds during
differentiation (days 0–8).22 On day 8, the differentiated adipocytes
were stained with Oil Red O solution, and the lipid contents were
quantified spectrophotometrically at 544 nm, which enables the
analysis of the structure–activity relationship for these com-
Supplementary data
2
3
pounds. Compounds 1–3 and 7–9 were found to significantly re-
duce lipid accumulation in 3T3-L1 preadipocytes, compared to
positive control, epigallocatechin-3-gallate (EGCG) (Table 2). Espe-
cially, compounds 1–3 with 1-hydroxy-6-oxo-2-cyclohexenecarb-
oxylate moiety exhibited more potent inhibitory activities on
adipocyte differentiation than the other compounds. In previous
Letter, idescarpin (1) and 1-hydroxy-6-oxo-2-cyclohexenecarboxy-
lic acid inhibited lipopolysaccharide-induced nitric oxide produc-
tion in BV2 microglia.12 Idesolide (3) also were reported to
References and notes
1
2
.
.
4
5
6
.
.
.
inhibit adipogenic differentiation of mesenchymal cells through
suppression of nitric oxide production.13 Therefore, it can be sug-
7.
gested that the 1-hydroxy-6-oxo-2-cyclohexenecarboxylate moi-
ety importantly contribute to the anti-adipogenic activity of
compounds 1–3. For more accurate examination of the structure
activity relationship, further study should investigate the inhibi-
tory effect of adipocyte differentiation of other compounds with
more structural variety. Among the compounds 1–3, idescarpin
1
1
1
4. Compound 8 (2 mg) was dissolved in 6 N HCl and the solution was heated to
90 °C for 2 h. After neutralizing acidic solution with silver carbonate, the
(
1) showed the most potent inhibitory activity on adipocyte differ-
entiation with IC50 values of 23.2 M. As shown in Fig. 2B, fat drop-
let formation was decreased at concentrations of 25 and 50 M,
1
l
solvent was evaporated to dryness under
extracted with EtOAc and H O, successively, and the aqueous layer was
concentrated to dryness. The dried reactant was subjected to Hydrophilic
interaction liquid chromatography–electrospray ionisation-mass spectrometry
(HILIC–ESI-MS). The HPLC–ESI-MS system consisted of a Finnigan Surveyor
HPLC system with a pump, an autosampler and the Finnigan LCQ Advantage
2
N . The reaction mixture was
l
2
indicated by Oil Red O staining. The idescarpin (1) on gene and pro-
tein expression of adipokines was elucidated by real-time PCR and
Western blot analysis, respectively, compared with the fully differ-
entiated adipocytes without sample treatment at the gene level
Ò
with Xcalibur software. Separation was achieved at 30 °C on a ZIC -HILIC
2
4,25
(
Fig. 2C).
Adipocyte differentiation causes a series of pro-
and C/EBP
column (5 mm, 4.6 mm id ꢀ 100 mm, SeQuant AB). The mass spectrometer
grammed changes in specific gene expressions. PPAR
c
a
was operated with the ion source voltage set to ꢁ3000 V, capillary voltage
ꢁ
30 V, capillary temperature 300 °C, tube lens offset ꢁ60 V, sheath gas 40
are at the center of this network and oversee the entire terminal
(
arbitrary units) and auxiliary gas 30 (arbitrary units). The mobile solvent
differentiation process.26 Idescarpin (1) dramatically suppressed
consisted of (A) 0.03% formic acid in water and (B) 100% acetonitrile at a flow
the induction of C/EBP
creased the induction of PPAR
a
expression, whereas it significantly in-
expression at concentrations of
1
c